#USA #Saudi Arabia #Salt Lake City #Co-Diagnostics #Dwight Egan

Co-Diagnostics to Host a Fireside Chat

Co-Diagnostics, Inc., well-known for its cutting-edge molecular diagnostic tools, is set to hold an engaging virtual fireside chat on November 5, 2025, at 11:00 AM ET. This discussion will feature the company's CEO, Dwight Egan, who will provide critical updates regarding Co-Diagnostics' recent initiatives, including a significant agreement with Arabian Eagle in Saudi Arabia.

The significance of this agreement cannot be overstated. The partnership aims to establish CoMira Diagnostics, which will facilitate the regional deployment of Co-Dx's unique PCR platform throughout the Middle East. This collaboration represents a major step forward in the company’s strategy to enhance its presence and offerings in international markets.

Event Details

• - Date: November 5, 2025
• - Time: 11:00 AM ET
• - Registration Link: Register Here

During the session, participants will have the opportunity to gain insights into the company's growth strategies and future directions. The chat will also include a Q&A segment, allowing attendees to engage with the CEO directly. To optimize the discussion, participants are encouraged to submit their questions ahead of time via email.

Egan expressed his excitement about the forthcoming chat, stating, “We are thrilled to share our progress and discuss how our innovative technologies will make a positive impact in the medical diagnostics field, particularly in collaboration with our partners in Saudi Arabia.”

Co-Diagnostics Overview

Founded in Utah, Co-Diagnostics, Inc. develops and markets sophisticated diagnostics technologies aimed at detecting and analyzing nucleic acid molecules, crucial for various medical applications. The company's proprietary systems, including the Co-Dx PCR platform, are designed to provide accurate and timely diagnostics and are currently subject to regulatory review. Though they are not available for sale yet, the company is progressing towards making these essential tools accessible.

By establishing partnerships like the one with Arabian Eagle, Co-Diagnostics seeks to not only enhance its technological reach but also contribute to improving healthcare outcomes across regions. This move distinctly aligns with global health initiatives, aiming to provide accessible and reliable diagnostic solutions in rapidly evolving markets.

This upcoming fireside chat is positioned as a pivotal event for stakeholders, investors, and the healthcare community, shedding light on how leading-edge diagnostic innovation can transform healthcare practices, especially in areas where access to sophisticated testing is critical.

For additional information or to participate in the event, make sure to visit Co-Diagnostics' Investor Relations webpage post-event, where a recording of the chat will also be made available.

In conclusion, Co-Diagnostics stands at the forefront of an inspiring journey within the molecular diagnostics arena, and the upcoming fireside chat promises to offer invaluable insights into their strategic endeavors and future ambitions. Don't miss this opportunity to engage with leaders in the field and learn more about their groundbreaking work in the healthcare landscape.